21
May
2020
Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments Read more
20
May
2020
A UK Supreme Court justice, a former USPTO acting director, a globally-renowned IP scholar, a trailblazing trademark lawyer and a one-time presidential candidate form the class of 2020 Read more
15
May
2020
From key case law to radical new ways of working, four leading experts share their predictions about what might happen next at the board Read more
14
May
2020
Leading experts put recent changes to post-issuance reviews under the microscope and like what they see Read more
